Source: Rheumatology international. Unidade: FM
Subjects: DOENÇA CELÍACA, MANIFESTAÇÕES CUTÂNEAS, DOENÇAS REUMÁTICAS, FÁRMACOS IMUNOSSUPRESSORES (APLICAÇÕES TERAPÊUTICAS), ESTOMATITE AFTOSA, PATOLOGIA BUCAL, ÚLCERA GASTRODUODENAL, RECIDIVA, CITOCINAS (ANÁLISE)
ABNT
AIKAWA, Nádia Emi et al. Late response to anti-TNF-alfa therapy in refractory mucocutaneous lesions of Behçet's disease. Rheumatology international, v. 31, n. 8, p. 1097-1099, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00296-009-1276-x. Acesso em: 03 nov. 2024.APA
Aikawa, N. E., Gonçalves, C., Silva, C. A. A., Gonçalves, C., Bonfa, E. S. D. de O., & Carvalho, J. F. de. (2011). Late response to anti-TNF-alfa therapy in refractory mucocutaneous lesions of Behçet's disease. Rheumatology international, 31( 8), 1097-1099. doi:10.1007/s00296-009-1276-xNLM
Aikawa NE, Gonçalves C, Silva CAA, Gonçalves C, Bonfa ESD de O, Carvalho JF de. Late response to anti-TNF-alfa therapy in refractory mucocutaneous lesions of Behçet's disease [Internet]. Rheumatology international. 2011 ; 31( 8): 1097-1099.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00296-009-1276-xVancouver
Aikawa NE, Gonçalves C, Silva CAA, Gonçalves C, Bonfa ESD de O, Carvalho JF de. Late response to anti-TNF-alfa therapy in refractory mucocutaneous lesions of Behçet's disease [Internet]. Rheumatology international. 2011 ; 31( 8): 1097-1099.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00296-009-1276-x